251 related articles for article (PubMed ID: 17662007)
1. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis.
Ljøstad U; Skarpaas T; Mygland A
Eur J Neurol; 2007 Aug; 14(8):873-6. PubMed ID: 17662007
[TBL] [Abstract][Full Text] [Related]
2. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis--the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic.
Djukic M; Schmidt-Samoa C; Nau R; von Steinbüchel N; Eiffert H; Schmidt H
Eur J Neurol; 2011 Apr; 18(4):547-55. PubMed ID: 20977545
[TBL] [Abstract][Full Text] [Related]
4. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
[TBL] [Abstract][Full Text] [Related]
5. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.
Mygland A; Ljøstad U; Fingerle V; Rupprecht T; Schmutzhard E; Steiner I;
Eur J Neurol; 2010 Jan; 17(1):8-16, e1-4. PubMed ID: 19930447
[TBL] [Abstract][Full Text] [Related]
6. CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland Å
J Neurol; 2008 May; 255(5):782. PubMed ID: 27517589
[TBL] [Abstract][Full Text] [Related]
7. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients.
Blanc F; Jaulhac B; Fleury M; de Seze J; de Martino SJ; Remy V; Blaison G; Hansmann Y; Christmann D; Tranchant C
Neurology; 2007 Sep; 69(10):953-8. PubMed ID: 17785663
[TBL] [Abstract][Full Text] [Related]
8. Does more favourable handling of the cerebrospinal fluid increase the diagnostic sensitivity of Borrelia burgdorferi sensu lato-specific PCR in Lyme neuroborreliosis?
Forselv KJN; Lorentzen ÅR; Ljøstad U; Mygland Å; Eikeland R; Kjelland V; Noraas S; Quarsten H
Infect Dis (Lond); 2018 Apr; 50(4):297-302. PubMed ID: 29125008
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study.
Tetens MM; Dessau R; Ellermann-Eriksen S; Andersen NS; Jørgensen CS; Østergaard C; Bodilsen J; Damgaard DF; Bangsborg J; Nielsen AC; Møller JK; Omland LH; Obel N; Lebech AM
Clin Microbiol Infect; 2022 Nov; 28(11):1500.e1-1500.e6. PubMed ID: 35709901
[TBL] [Abstract][Full Text] [Related]
10. Direct Molecular Detection and Genotyping of Borrelia burgdorferi Sensu Lato in Cerebrospinal Fluid of Children with Lyme Neuroborreliosis.
Barstad B; Quarsten H; Tveitnes D; Noraas S; Ask IS; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29467195
[TBL] [Abstract][Full Text] [Related]
11. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].
Rupprecht TA; Lechner C; Tumani H; Fingerle V
Nervenarzt; 2014 Apr; 85(4):459-64. PubMed ID: 24682168
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
Wutte N; Archelos J; Crowe BA; Zenz W; Daghofer E; Fazekas F; Aberer E
J Neurol Sci; 2014 Dec; 347(1-2):96-103. PubMed ID: 25288328
[TBL] [Abstract][Full Text] [Related]
13. C6-peptide serology as diagnostic tool in neuroborreliosis.
Tjernberg I; Schön T; Ernerudh J; Wistedt AC; Forsberg P; Eliasson I
APMIS; 2008 May; 116(5):393-9. PubMed ID: 18452429
[TBL] [Abstract][Full Text] [Related]
14. No correlation between symptom duration and intrathecal production of IgM and/or IgG antibodies in Lyme neuroborreliosis - a retrospective cohort study in Denmark.
Krogen I; Skarphédinsson S; Jensen TG; Knudtzen FC
J Infect; 2022 Nov; 85(5):507-512. PubMed ID: 36122734
[TBL] [Abstract][Full Text] [Related]
15. Lyme neuroborreliosis with antibodies in cerebrospinal fluid but not in serum.
Zomer TP; Bruinsma R; van Samkar A; Vermeeren YM; Wieberdink RG; van Kooten B; van Bemmel T
Eur J Neurol; 2023 Mar; 30(3):741-744. PubMed ID: 36371644
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
[TBL] [Abstract][Full Text] [Related]
17. Value of clinical symptoms, intrathecal specific antibody production and PCR in CSF in the diagnosis of childhood Lyme neuroborreliosis.
Issakainen J; Gnehm HE; Lucchini GM; Zbinden R
Klin Padiatr; 1996; 208(3):106-9. PubMed ID: 8676596
[TBL] [Abstract][Full Text] [Related]
18. Lyme neuroborreliosis: a treatable cause of acute ocular motor disturbances in children.
Correll MH; Datta N; Arvidsson HS; Melsom HA; Thielberg AK; Bjerager M; Brodsky MC; Saunte JP
Br J Ophthalmol; 2015 Oct; 99(10):1401-4. PubMed ID: 25868792
[TBL] [Abstract][Full Text] [Related]
19. The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid.
Vermeersch P; Resseler S; Nackers E; Lagrou K
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):347-9. PubMed ID: 19376674
[TBL] [Abstract][Full Text] [Related]
20. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.
Skogman BH; Lager M; Henningsson AJ; Tjernberg I
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
